ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,358,682 | -28.5% | 50,565 | -5.1% | 0.02% | -26.1% |
| Q2 2023 | $1,900,321 | +34.5% | 53,290 | -4.2% | 0.02% | +27.8% |
| Q1 2023 | $1,412,545 | -68.0% | 55,612 | -49.0% | 0.02% | -37.9% |
| Q4 2022 | $4,420,554 | +143.2% | 108,988 | +98.2% | 0.03% | +11.5% |
| Q3 2022 | $1,818,000 | -14.1% | 54,994 | -8.5% | 0.03% | -7.1% |
| Q2 2022 | $2,117,000 | -18.6% | 60,130 | +6.3% | 0.03% | 0.0% |
| Q1 2022 | $2,602,000 | -27.6% | 56,575 | +4.4% | 0.03% | -24.3% |
| Q4 2021 | $3,594,000 | – | 54,201 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |